Tags : Immune

Arena Signs a Multi-Year Agreement with Beacon Discovery to Develop

Shots: Beacon will take care of drug discovery activities while Arena will focus on development and commercialization of products for multiple immune and inflammatory diseases The focus of the agreement is to develop therapies for G protein-coupled receptor (GPCR) targets and further expanding the footprints in autoimmune diseases Arena has a pipeline of three candidates […]Read More